Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-specific immunological function in acute myeloblastic leukaemia

A Foy, M N Cauchi, M G Whiteside

    Pathology
    |April 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Internal medicine in the bush: a clinical audit of a rural and remote outreach programme.

    Internal medicine journal·2014
    Same author

    Marijuana 'bong' smoking and tuberculosis.

    Internal medicine journal·2013
    Same author

    Primary hypothyroidism masquerading as hepatocellular necrosis.

    QJM : monthly journal of the Association of Physicians·2013
    Same author

    Alcohol problems in a general hospital.

    Addiction biology·2010
    Same author

    Circuit breakers for addiction.

    Internal medicine journal·2007
    Same author

    Successful surgical treatment of protein-losing enteropathy complicating rheumatic tricuspid regurgitation.

    Heart, lung & circulation·2007
    Same journal

    Impact of the 2025 Endocrine Society clinical practice guideline on the diagnosis and management of primary aldosteronism for the clinical laboratory.

    Pathology·2026
    Same journal

    Cribriform intraductal carcinoma of the prostate may have a greater prognostic impact even than Gleason grade 5 conventional prostatic adenocarcinoma.

    Pathology·2026
    Same journal

    Bordetella pertussis: emerging epidemiology, diagnosis and management.

    Pathology·2026
    Same journal

    Development and validation of a real-time polymerase chain reaction for the detection of Haycocknema perplexum.

    Pathology·2026
    Same journal

    Recent advances in the understanding of TP53 in haematological malignancies.

    Pathology·2026
    Same journal

    Concurrent renal amyloid light chain amyloidosis, light chain crystalline podocytopathy and light chain proximal tubulopathy: a case report.

    Pathology·2026
    See all related articles

    This study investigated immunological function in acute myeloblastic leukemia (AML) patients. Impaired immune responses and PHA stimulation in remission suggest potential relapse indicators.

    Area of Science:

    • Immunology
    • Hematology
    • Oncology

    Background:

    • Acute myeloblastic leukemia (AML) is a cancer affecting blood and bone marrow.
    • Understanding immunological function in AML patients is crucial for prognosis and treatment.
    • Immune system alterations are common in leukemia patients.

    Purpose of the Study:

    • To investigate immunological function in untreated and remission stages of AML.
    • To assess immunoglobulin and auto-antibody levels in AML patients.
    • To evaluate cellular immune responses, including skin tests and lymphocyte stimulation, in AML.

    Main Methods:

    • Analysis of immunoglobulin (IgM, IgG, IgA) and complement (C') concentrations.
    • Detection of auto-antibodies against normal tissue components.

    Related Experiment Videos

  • Standard skin testing to assess cellular immunity.
  • Phytohemagglutinin (PHA) stimulation assay for lymphocyte function.

    • Main Results:

    • Elevated IgM levels observed in 7/29 untreated AML patients.
    • Minimal changes in IgG, IgA, C', and auto-antibody incidence.
    • Significantly impaired skin test reactivity in AML patients in remission (2/10 responded).
    • Variable PHA lymphocyte stimulation in remission, with <40% response correlating with shorter remission duration.

    Conclusions:

    • AML patients exhibit significant immune dysfunction, particularly in cellular immunity.
    • PHA stimulation of lymphocytes may serve as a predictive marker for AML relapse.
    • Further research into immune modulation in AML is warranted.